PerkinElmer
FDA Issues Emergency Use Authorization for PerkinElmer COVID-19/Flu Test
The RT-PCR-based test can detect and differentiate SARS-CoV-2, flu A/B, and RSV using nasopharyngeal, anterior nasal, and mid-turbinate swabs.
In Brief This Week: PerkinElmer, Chembio, Becton Dickinson, Fulgent Genetics, and More
News items for the in vitro diagnostic industry for the week of Sept. 20, 2021.
PerkinElmer Prices Senior Notes Offering
The $2.3 billion offering will provide some of the money PerkinElmer needs to complete its planned acquisition of BioLegend.
PerkinElmer Reaches Deal for $1.5B Credit Facility
The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.
In Brief This Week: PerkinElmer, Quidel, Abbott, Labcorp, Guardant Health, and More
News items for the in vitro diagnostics industry for the week of Aug. 9, 2021.
Aug 12, 2021
PerkinElmer Enters $500M Credit Facility
Jul 9, 2021
Jun 2, 2021
Mar 23, 2021
Mar 4, 2021
PerkinElmer to Offer $800M in Senior Notes
Feb 23, 2021
PerkinElmer COVID-19 Rapid Antigen Test Gets CE Mark
Feb 2, 2021